These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 34096653)

  • 1. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
    Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
    Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series.
    Naruka S; Rana N; Singh N; Kishore A; Nagpal K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):134S-144S. PubMed ID: 35176884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt.
    Alfishawy M; Elbendary A; Younes A; Negm A; Hassan WS; Osman SH; Nassar M; Elanany MG
    Diabetes Metab Syndr; 2021; 15(5):102195. PubMed ID: 34314921
    [No Abstract]   [Full Text] [Related]  

  • 5. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
    Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
    Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study.
    Eshraghi B; Khademi B; Mirmohammadkhani M; Khataminia G; Ghahvehchian H; Kiarudi MY; Nabie R; Parandin M; Ghasemi Boroumand P; Mohammadi R; Zia Z; Karamirad S; Jafarpour S; Fakoor M; Varshochi M; Shahraki K; Memarzadeh M; Janipour M; Mahdian Rad A; Kashkouli MB; Shekarchian F; Manouchehri V; Khosravi A; Abounoori M; Shahir A; Sajjadi SMJ; Etezad Razavi M; Hosseini NS; Ebrahimi F; Noorshargh P; Forouhari A; Pourazizi M
    BMC Infect Dis; 2024 Aug; 24(1):852. PubMed ID: 39174954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study.
    Sahin M; Yilmaz M; Mert A; Naghili B; Ravanbakhsh F; Varshochi M; Darazam IA; Ebrahimi MJ; Moafi M; Tehrani HA; Mahboob A; Rashid N; Khan EA; Hakamifard A; Eser-Karlidag G; Babamahmoodi A; El-Kholy A; Mosawi SH; Albayrak A; Al Ramahi JW; Addepalli SK; Özer Balin Ş; Khan A; Pandya N; Gurbuz E; Sincan G; Azami H; Dumlu R; Khedr R; Ripon RK; Alkan S; Kose Ş; Ceylan B; Erdem H
    Med Mycol; 2024 Jul; 62(7):. PubMed ID: 38914466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
    Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
    Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.
    Aggarwal SK; Kaur U; Talda D; Pandey A; Jaiswal S; Kanakan A; Singh A; Chakrabarti SS
    Am J Trop Med Hyg; 2021 Dec; 106(2):566-570. PubMed ID: 34902834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Disease-19-associated Mucormycosis: A Single-center Observational Study of 69 Patients.
    Yadav DS; Chavan SA; Karnik ND; Kumar CA; Padhiyar RN; D'Souza D
    J Assoc Physicians India; 2024 Oct; 72(10):24-31. PubMed ID: 39390855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating pattern of rhino-orbital-cerebral mucormycosis with COVID-19 in diabetic patients.
    Eker C; Tarkan O; Surmelioglu O; Dagkiran M; Tanrisever I; Yucel Karakaya SP; Ulas B; Onan E; Uguz AH; Ozdemir S
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):219-226. PubMed ID: 35768700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study.
    Manesh A; Devasagayam E; Bhanuprasad K; Varghese L; Kurien R; Cherian LM; Dayanand D; George MM; Kumar SS; Karthik R; Vanjare H; Peter J; Michael JS; Thomas M; Mathew BS; Samuel P; Peerawaranun P; Mukaka M; Rupa V; Varghese GM
    Clin Microbiol Infect; 2023 Oct; 29(10):1298-1305. PubMed ID: 37348653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: 'Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis' by Manesh et al.
    Muthu V; Agarwal R; Chakrabarti A
    Clin Microbiol Infect; 2023 Nov; 29(11):1461-1462. PubMed ID: 37473841
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.